Company profile for JanOne

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for prescribing dangerous opioid drugs. Our first drug candidate is a treatment for Peripheral Arterial Disease (PAD), a condition that can cause severe pain and affects over 8.5 million people in the US alone. ...
JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. As a result, we hope to reduce the need for prescribing dangerous opioid drugs. Our first drug candidate is a treatment for Peripheral Arterial Disease (PAD), a condition that can cause severe pain and affects over 8.5 million people in the US alone. The company trades under the symbol JAN on the NASDAQ and continues to independently operate its subsidiary business – Appliance Recycling Centers of America, Inc (ARCA).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
325 East Warm Springs Road Suite 102 Las Vegas, NV 89119
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/janone-regains-compliance-with-nasdaqs-listing-requirements-302089923.html

PR NEWSWIRE
15 Mar 2024

https://www.prnewswire.com/news-releases/janone-to-present-at-the-dawson-james-8th-annual-investment-conference-301935142.html

PR NEWSWIRE
21 Sep 2023

https://www.prnewswire.com/news-releases/janone-to-present-in-person-and-by-video-at-hc-wainwrights-25th-annual-global-investment-conference-301914628.html

PR NEWSWIRE
31 Aug 2023

https://www.prnewswire.com/news-releases/janone-wins-best-abstract-award-at-the-ohio-society-of-interventional-pain-physicians-annual-meeting-301910293.html

PR NEWSWIRE
25 Aug 2023

https://www.prnewswire.com/news-releases/janone-technologies-announces-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-301904870.html

PR NEWSWIRE
18 Aug 2023

https://www.prnewswire.com/news-releases/janone-files-international-patent-application-for-methods-of-using-low-dose-naltrexone-to-treat-chronic-pain-301865422.html

PR NEWSWIRE
28 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty